Evidence-Based Neonatology - EBNEO

Hem
Sverige
Stockholm
Evidence-Based Neonatology - EBNEO

The non-profit international society promoting best neonatal practice by disseminating its EBM liter Follow us to stay current with the neonatal literature.

The international society promoting best neonatal practice by disseminating its EBM literature: curate, assess, survey.

30/12/2025

Follow-up from the STOP-BPD trial, a multicenter trial of post-natal hydrocortisone among mechanically ventilated preterm infants in the Netherlands and Belgium, at 5.5 years corrected age did not find any differences in death or moderate-severe neurodevelopmental impairment. https://buff.ly/DvL0YVe

29/12/2025

Population-based cohort study using the French National Health System Database compares RSV hospitalizations among infants receiving Nirsevimab and those exposed to Maternal vaccination with RSVpreF. https://buff.ly/eETIk5a

27/12/2025

Retrospective cohort study using evaluates the impact of probiotics on severe NEC and other outcomes using a propensity score-matched cohort.
https://buff.ly/aR1yp9s

22/12/2025

Researchers examine how access to maternity care at the county level is associated w/risk of infant mortality https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2841239

19/12/2025

Targeted Oxygen for Preterm Resuscitation: A randomized trial of >1400 infants (23–28 wks) found no change in death or brain injury when resuscitation began with FiO₂ 0.6 vs 0.3. https://buff.ly/sz18j6x

19/12/2025

New school-age results from the Hydrocortisone for BPD Trial show that very preterm children who received hydrocortisone had no differences in functional outcomes at 5–7 years compared with those who received placebo and no evidence of harm. This prospective follow-up of the Hydrocortisone for BPD Trial included infants born

11/12/2025

New evidence on how to manage a PDA: Laughon et al. publish results of the NRN PDA RCT in
https://buff.ly/ZTQ3ByJ

09/12/2025

School-age follow up outcomes of the Hydrocortisone for BPD trial by DeMauro et al in
https://buff.ly/k7ue8Zr

06/12/2025

Zar's Clesrovimab vs Eichenwald's extended caffeine:
Which RCT posted by during November is more likely to impact your practice?
Vote is now open on our website
www.ebneo.org/vote

03/12/2025

Antenatal betamethasone administration in women with twin pregnancies at risk of late preterm delivery significantly reduced the risk of neonatal respiratory morbidity in this multicenter RCT.
https://buff.ly/FMpRC2m

01/12/2025

How does a low-dose probiotic strategy compare with a high-dose approach in reducing NEC or mortality in preterm infants? A new RCT in addresses this question.
https://buff.ly/XgfIADX

30/11/2025

Would extending caffeine therapy through 42 weeks’ postmenstrual age reduce intermittent hypoxia in convalescing preterm infants? ICAF trial published https://buff.ly/VBBAU5A

Adress

Stockholm
17176

Webbplats

https://ebneo.org/

Aviseringar

Var den första att veta och låt oss skicka ett mail när Evidence-Based Neonatology - EBNEO postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Kontakta Praktiken

Skicka ett meddelande till Evidence-Based Neonatology - EBNEO:

Genvägar

Vill du placera din praktik längst upp i Klinik-listan i Stockholm?

Dela

Typ

Medicinskt forskningscenter

Our story

The international society promoting best neonatal practice by disseminating its evidence-based literature: #ebneoalerts curate, #ebneoreviews assess, #ebneopolls survey. Follow us to narrow your evidence-practice gap by staying up to date with the neonatal literature.